HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Felipe Campesato Selected Research

Luis Felipe Campesato Research Topics

Disease

10Neoplasms (Cancer)
01/2024 - 11/2016
2Melanoma (Melanoma, Malignant)
01/2024 - 12/2021
1Carcinoma (Carcinomatosis)
11/2021
1Experimental Melanoma
11/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Adenocarcinoma
01/2020
1Breast Neoplasms (Breast Cancer)
07/2017

Drug/Important Bio-Agent (IBA)

2eprenetapoptIBA
01/2024 - 01/2022
2Immune Checkpoint InhibitorsIBA
11/2021 - 11/2020
1VaccinesIBA
01/2024
1Immunomodulating AgentsIBA
01/2024
1pembrolizumabIBA
01/2022
1PhosphatidylserinesIBA
12/2021
1Protein Isoforms (Isoforms)IBA
11/2021
1EnzymesIBA
11/2020
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2020
1Tryptophan (L-Tryptophan)FDA Link
11/2020
1Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA
11/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020
1CytokinesIBA
01/2020
1Conditioned Culture MediaIBA
01/2020
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2019
1Therapeutic UsesIBA
01/2019
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2017
1Programmed Cell Death 1 ReceptorIBA
11/2016
1AntibodiesIBA
11/2016
1Proteins (Proteins, Gene)FDA Link
11/2016
1B7-H1 AntigenIBA
11/2016

Therapy/Procedure

4Immunotherapy
11/2020 - 11/2016
3Therapeutics
11/2021 - 07/2017
2Radiotherapy
12/2021 - 01/2020
1Drug Therapy (Chemotherapy)
01/2020